I beg to move,
That this House has considered funding for GAVI, the Vaccine Alliance, and the Global Fund.
It is a pleasure to serve under your chairpersonship, Ms Jardine. I want to start with a quote from Gavi’s inaugural board chair, Nelson Mandela, over 20 years ago:
“Life or death for a young child too often depends on whether he”—
or she—
“is born in a country where vaccines are available”.
It is the injustice that he spoke of that the organisations we will talk about today—Gavi, the Global Fund and others—have fought against since Gavi was established in 2000. The fight has led to more than 1 billion children being vaccinated, and more than 18 million avoidable deaths prevented in low-income countries.
This is also a Labour and UK story. We had a consensus, but it was Tony Blair’s championing of Gavi at its launch in 2000, and Gordon Brown’s leading role in the creation of the international finance facility for immunisation, that helped to fund Gavi’s work at the start, and the organisation continues to turn to our Government —a Labour Government—for global leadership.
Through these organisations, we have cut the combined death rate from AIDS-related illnesses, tuberculosis and malaria by an incredible 61%, saving 65 million lives. Childhood mortality in under-fives has been reduced by over 50%, and vaccine-preventable deaths by over 70%, in the places where Gavi operates, and the coverage of key treatment and prevention interventions for HIV, TB and malaria has increased significantly in countries where the Global Fund invests. We saw TB treatment coverage increase from 45% in 2010 to 70% in 2022. In 2010 the percentage of the population with access to long-lasting insecticide-treated nets to prevent malaria was only 30%; in 2023 it reached 57%. In 2010 only 22% of people living with HIV were on antiretroviral therapy; in 2023 it reached 78%. That is the UK’s legacy.
We hosted the first replenishment for Gavi in 2011, we hosted the last one in 2020, and we will co-host the Global Fund replenishment this year alongside South Africa. This is not just about helping other countries; it is about the UK’s own soft power and security and the resilience of the NHS.
Let us talk a bit more about the UK’s contribution, because it is not just the Government’s contribution, but the contribution of amazing life sciences companies here in the UK. The UK Vaccine Network helped to develop life-saving vaccines such as the RTS,S malaria vaccine and the Oxford-AstraZeneca covid-19 vaccine, which have both been procured and rolled out by Gavi worldwide. Between 2016 and 2022 we invested £134 million to develop new vaccines for epidemic-prone diseases. An additional £103.5 million was committed in 2023 to support affordable vaccine development. Three billion doses of the covid vaccine have been supplied globally, which is estimated to have saved over 6 million lives in the first year of roll-out.